QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
NASDAQ:ESPR

Esperion Therapeutics Institutional Ownership

$5.56
-0.05 (-0.89%)
(As of 12/7/2021 04:00 PM ET)
Add
Compare
Today's Range
$5.39
$5.72
50-Day Range
$5.25
$12.62
52-Week Range
$4.96
$39.49
Volume
4.45 million shs
Average Volume
1.03 million shs
Market Capitalization
$161.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.91

Institutional Ownership Changes (13F Filings) for Esperion Therapeutics (NASDAQ:ESPR)

Current
Institutional Ownership
Percentage
98.80%

Number of
Institutional Buyers
(last 12 months)
89

Total
Institutional Inflows
(last 12 months)
$140.55 M

Number of
Institutional Sellers
(last 12 months)
65

Total
Institutional Outflows
(last 12 months)
$125.33 M

Skip Chart & View Institutional Buying and Selling Data

Institutional Buying and Selling by Quarter


Esperion Therapeutics (NASDAQ ESPR) Institutional Buying and Selling

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/18/2021Bank of New York Mellon Corp92,049$1.11M0.0%+9.9%0.317%
11/17/2021Centiva Capital LP15,038$0.18M0.0%N/A0.052%
11/16/2021Schonfeld Strategic Advisors LLC13,757$0.17M0.0%-77.1%0.047%
11/16/2021Cetera Advisor Networks LLC13,025$0.16M0.0%+29.6%0.045%
11/16/2021BNP Paribas Arbitrage SA254,774$3.07M0.0%+24,877.8%0.876%
11/16/2021Squarepoint Ops LLC72,499$0.87M0.0%+84.8%0.249%
11/16/2021UBS Group AG34,516$0.42M0.0%-35.0%0.119%
11/16/2021Voloridge Investment Management LLC256,761$3.09M0.0%+296.3%0.883%
11/16/2021Maverick Capital Ltd.49,973$0.60M0.0%+11.1%0.172%
11/16/2021Millennium Management LLC467,298$5.63M0.0%+47.4%1.607%
11/16/2021Centiva Capital LP15,038$0.18M0.0%N/A0.052%
11/15/2021Cubist Systematic Strategies LLC146,943$1.77M0.0%+874.1%0.505%
11/15/2021Man Group plc15,756$0.19M0.0%+14.4%0.054%
11/15/2021California State Teachers Retirement System34,360$0.41M0.0%-5.1%0.118%
11/15/2021Tudor Investment Corp Et Al70,571$0.85M0.0%+140.6%0.243%
11/15/2021Marshall Wace LLP520,095$6.27M0.0%-55.6%1.789%
11/15/2021Morgan Stanley451,824$5.44M0.0%+16.9%1.554%
11/15/2021Invesco Ltd.12,667$0.15M0.0%+19.2%0.044%
11/15/2021Virtus ETF Advisers LLC17,773$0.21M0.1%-8.4%0.061%
11/15/2021Granahan Investment Management Inc. MA293,766$3.54M0.1%-11.8%1.010%
11/15/2021Cinctive Capital Management LP110,558$1.33M0.1%-61.4%0.380%
11/15/2021Linden Advisors LP116,827$1.41M0.0%N/A0.402%
11/15/2021GSA Capital Partners LLP23,628$0.29M0.0%N/A0.081%
11/12/2021Jump Financial LLC27,000$0.33M0.0%N/A0.093%
11/12/2021Wasatch Advisors Inc.3,274,360$39.46M0.2%-13.1%11.261%
11/12/2021Jacob Asset Management of New York LLC47,534$0.57M0.2%-26.2%0.163%
11/12/2021Credit Suisse AG259,068$3.12M0.0%+159.7%0.891%
11/12/2021Geode Capital Management LLC341,871$4.12M0.0%-24.2%1.176%
11/12/2021Rhenman & Partners Asset Management AB622,267$7.50M0.5%+8.7%2.140%
11/10/2021Goldman Sachs Group Inc.27,553$0.33M0.0%-28.4%0.095%
11/10/2021Allianz Asset Management GmbH15,205$0.18M0.0%-22.8%0.052%
11/10/2021Citigroup Inc.5,085$61K0.0%-96.7%0.017%
11/9/2021Barclays PLC48,606$0.59M0.0%+41.7%0.167%
11/9/2021BlackRock Inc.2,006,134$24.17M0.0%-3.8%6.899%
11/9/2021M&G Investment Management Ltd.21,273$0.26M0.0%-41.0%0.073%
11/8/2021Duality Advisers LP42,213$0.51M0.0%N/A0.145%
11/8/2021Russell Investments Group Ltd.94,505$1.14M0.0%N/A0.325%
11/5/2021Resources Investment Advisors LLC.37,095$0.45M0.0%+123.5%0.131%
11/4/2021Deutsche Bank AG19,030$0.23M0.0%-4.9%0.067%
11/1/2021Independent Advisor Alliance11,500$0.14M0.0%N/A0.041%
11/1/2021SG Americas Securities LLC101,580$1.22M0.0%+633.7%0.359%
10/21/2021Virginia Retirement Systems ET AL48,800$0.59M0.0%N/A0.173%
10/19/2021Pinnacle Associates Ltd.260,959$3.15M0.1%-3.8%0.923%
9/17/2021Virtu Financial LLC13,480$0.29M0.0%N/A0.048%
9/3/2021Parametric Portfolio Associates LLC45,703$0.97M0.0%-20.3%0.162%
8/25/2021Marshall Wace LLP1,172,070$24.79M0.1%+13.8%4.145%
8/23/2021Morgan Stanley386,515$8.18M0.0%+258.9%1.367%
8/17/2021Wells Fargo & Company MN26,990$0.57M0.0%+160.9%0.095%
8/17/2021Invesco Ltd.10,630$0.23M0.0%N/A0.038%
8/17/2021Maverick Capital Ltd.44,992$0.95M0.0%N/A0.159%
8/17/2021Metropolitan Life Insurance Co NY7,777$0.16M0.0%+97,112.5%0.028%
8/17/2021Millennium Management LLC316,933$6.70M0.0%-14.9%1.121%
8/17/2021Man Group plc13,778$0.29M0.0%-50.8%0.049%
8/16/2021Squarepoint Ops LLC39,236$0.83M0.0%+100.7%0.139%
8/16/2021Bank of America Corp DE26,128$0.55M0.0%-33.6%0.092%
8/16/2021M&G Investment Management Ltd.36,056$0.76M0.0%N/A0.128%
8/16/2021UBS Asset Management Americas Inc.33,476$0.71M0.0%+22.9%0.118%
8/16/2021PDT Partners LLC104,400$2.21M0.1%+522.2%0.369%
8/16/2021Cubist Systematic Strategies LLC15,085$0.32M0.0%-63.3%0.053%
8/16/2021California State Teachers Retirement System36,188$0.77M0.0%-7.3%0.128%
8/16/2021Occudo Quantitative Strategies LP10,583$0.22M0.0%N/A0.037%
8/16/2021First Trust Advisors LP10,241$0.22M0.0%+8.3%0.036%
8/16/2021Royal Bank of Canada6,550$0.14M0.0%+70.1%0.023%
8/16/2021Morgan Stanley386,515$8.18M0.0%+258.9%1.367%
8/16/2021Credit Suisse AG99,760$2.11M0.0%-14.1%0.353%
8/16/2021Schonfeld Strategic Advisors LLC60,065$1.27M0.0%N/A0.212%
8/16/2021Charles Schwab Investment Management Inc.190,497$4.03M0.0%+2.3%0.674%
8/16/2021State Street Corp2,252,194$47.63M0.0%+6.3%7.965%
8/16/2021Nuveen Asset Management LLC165,998$3.51M0.0%-22.5%0.587%
8/16/2021Goldman Sachs Group Inc.38,484$0.81M0.0%+117.2%0.136%
8/16/2021Marshall Wace LLP1,172,070$24.79M0.1%+13.8%4.145%
8/16/2021Allianz Asset Management GmbH19,705$0.42M0.0%-42.6%0.070%
8/13/2021Northern Trust Corp312,888$6.62M0.0%+2.6%1.107%
8/13/2021Stifel Financial Corp15,938$0.34M0.0%-39.9%0.056%
8/13/2021Geode Capital Management LLC450,965$9.54M0.0%+0.5%1.595%
8/13/2021Vanguard Group Inc.2,299,988$48.64M0.0%-0.8%8.134%
8/13/2021Bailard Inc.10,000$0.21M0.0%-56.5%0.035%
8/13/2021Rhenman & Partners Asset Management AB572,267$12.10M0.8%-3.4%2.024%
8/13/2021ProShare Advisors LLC11,875$0.25M0.0%+10.1%0.042%
8/12/2021Wasatch Advisors Inc.3,766,935$79.67M0.3%-8.5%13.322%
8/12/2021Lazard Asset Management LLC27,000$0.57M0.0%N/A0.095%
8/12/2021SG Americas Securities LLC13,844$0.29M0.0%-14.9%0.049%
8/12/2021Legal & General Group Plc19,208$0.41M0.0%-8.3%0.068%
8/12/2021JPMorgan Chase & Co.75,075$1.59M0.0%-39.8%0.265%
8/12/2021Bellevue Group AG4,519,164$95.58M0.9%+13.3%15.982%
8/11/2021Bank of New York Mellon Corp83,757$1.77M0.0%-17.3%0.296%
8/11/2021BlackRock Inc.2,085,347$44.11M0.0%-2.8%7.375%
8/11/2021Deutsche Bank AG20,015$0.42M0.0%-4.2%0.071%
8/11/2021Susquehanna Fundamental Investments LLC50,792$1.07M0.0%+486.6%0.180%
8/10/2021Virtus ETF Advisers LLC19,398$0.41M0.2%-8.3%0.069%
8/10/2021State Board of Administration of Florida Retirement System18,171$0.38M0.0%+46.4%0.064%
8/10/2021Citigroup Inc.153,373$3.24M0.0%-7.1%0.542%
8/10/2021Rafferty Asset Management LLC98,918$2.09M0.0%-9.9%0.350%
8/10/2021Credit Agricole S A7,300$0.15M0.0%+49.0%0.026%
8/9/2021Resources Investment Advisors LLC.16,595$0.35M0.0%-29.6%0.059%
8/6/2021Mutual of America Capital Management LLC73,662$1.56M0.0%-4.1%0.261%
8/6/2021Swiss National Bank52,400$1.11M0.0%-13.4%0.186%
8/5/2021Rhumbline Advisers32,878$0.70M0.0%+2.5%0.117%
8/2/2021New York State Common Retirement Fund49,543$1.05M0.0%-17.8%0.176%
8/2/2021Pinnacle Associates Ltd.271,204$5.74M0.1%+1.6%0.962%
(Data available from 1/1/2016 forward)













Esperion Therapeutics (NASDAQ:ESPR) Institutional Ownership Frequently Asked Questions

Who are the institutional owners of Esperion Therapeutics?

During the previous two years, 184 institutional investors and hedge funds held shares of Esperion Therapeutics. The most heavily invested institutionals were Bellevue Group AG ($95.58M), Meditor Group Ltd ($59.62M), Vanguard Group Inc. ($48.64M), State Street Corp ($47.63M), Platinum Investment Management Ltd. ($44.90M), Wasatch Advisors Inc. ($39.46M), and Avidity Partners Management LP ($28.72M).Learn more on ESPR's institutional investors

What percentage of Esperion Therapeutics stock is owned by institutional investors?

98.80% of Esperion Therapeutics stock is owned by institutional investors. Learn more on ESPR's institutional investor holdings

Which institutional investors have been buying Esperion Therapeutics stock?

Of the 162 institutional investors that purchased Esperion Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wasatch Advisors Inc. ($1.87M), Morgan Stanley ($0.82M), Bellevue Group AG ($0.80M), Point72 Asset Management L.P. ($0.65M), Norges Bank ($0.58M), Avidity Partners Management LP ($0.43M), and Rothschild & Co. Asset Management US Inc. ($0.37M).

How much institutional buying is happening at Esperion Therapeutics?

Institutional investors have bought a total of 12,695,520 shares in the last 24 months. This purchase volume represents approximately $424.55M in transactions.

Which Esperion Therapeutics institutionals have been selling company stock?

Of the 97 institutional investors that sold Esperion Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bellevue Group AG ($1.15M), Credit Suisse AG ($0.99M), Wasatch Advisors Inc. ($0.84M), Marshall Wace LLP ($0.65M), Nomura Holdings Inc. ($0.54M), Point72 Asset Management L.P. ($0.41M), and State Street Corp ($0.34M).

How much institutional selling is happening at Esperion Therapeutics?

Institutional investors have sold a total of 9,332,739 shares in the last 24 months. This volume of shares sold represents approximately $287.55M in transactions.

This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.